Stay updated on Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the usual content with an access-restricted notice. The additions include the 403 text and typical site header/footer indicating the page is blocked.SummaryDifference22%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 on the page, indicating a new revision of the study record metadata.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page now displays a server error (500) with an 'An error occurred' message, indicating the requested study page is currently unavailable. As a result, no study details are accessible at this time.SummaryDifference21%

- Check67 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a minor platform update. No study content changes are reflected in this update.SummaryDifference0.0%

- Check81 days agoChange DetectedAdded a new citation by Bocobo A. et al. to Publications for a 2026 Clin Colorectal Cancer article (Phase II study of pembrolizumab plus capecitabine and bevacizumab). Removed the previous Online ahead of print citation (Clin Colorectal Cancer, 2026 Feb 18:S1533-0028(26)00010-1).SummaryDifference0.0%

- Check88 days agoChange DetectedRevision tag on the page updated from v3.6.2 to v3.6.3, signaling a new patch or update to the page. The visible content remains unchanged.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.